Cingulate Inc. (CING)
$0.00+$0.00 (+0.00%) Latest sessionExtended Hours
Cingulate Inc is a clinical-stage biopharmaceutical company focused on the development of products utilizing its drug delivery platform technology that enables the formulation and manufacture of once-daily tablets of multi-dose therapies, with an initial focus on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety. The Company is developing two proprietary, first-line stimulant medications, CTx-1301 (dexmethylphenidate) and CTx-1302 (dextroamphetamine), for the treatment of ADHD intended for all patient segments: children, adolescents, and adults. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic areas to use PTR technology to develop future product candidates.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Grant or award | 14 | 678,885 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
33 Form 4 filings on record, the earliest from Oct 1, 2024, newest first. Filing history page 1 of 2.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Shane J. Schaffer - Officer | Grant or award | Stock Option (right to Buy) | 197,650 | $0.00 | - | |
| Shane J. Schaffer - Officer | Grant or award | Stock Option (right to Buy) | 97,350 | $0.00 | - | |
| Bryan Wade Downey - Officer | Grant or award | Stock Option (right to Buy) | 67,000 | $0.00 | - | |
| Bryan Wade Downey - Officer | Grant or award | Stock Option (right to Buy) | 33,000 | $0.00 | - | |
| Bryan Jay Lawrence - Director | Grant or award | Stock Option (right to Buy) | 20,000 | $0.00 | - | |
| Matthew Brams - Officer | Grant or award | Stock Option (right to Buy) | 53,600 | $0.00 | - | |
| Matthew Brams - Officer | Grant or award | Stock Option (right to Buy) | 26,400 | $0.00 | - | |
| Thomas Jeffrey Hargroves - Director | Grant or award | Stock Option (right to Buy) | 20,000 | $0.00 | - | |
| Jennifer L. Callahan - Officer | Grant or award | Stock Option (right to Buy) | 40,200 | $0.00 | - | |
| Jennifer L. Callahan - Officer | Grant or award | Stock Option (right to Buy) | 19,800 | $0.00 | - | |
| Peter J. Werth - Director | Grant or award | Stock Option (right to Buy) | 20,000 | $0.00 | - | |
| Raul R. Silva - Officer | Grant or award | Stock Option (right to Buy) | 53,600 | $0.00 | - | |
| Raul R. Silva - Officer | Grant or award | Stock Option (right to Buy) | 26,400 | $0.00 | - | |
| Raul R. Silva - Officer | Grant or award | Stock Option (right to Buy) | 3,885 | $0.00 | - | |
| Thomas Jeffrey Hargroves - Director | Open-market purchase | Common Stock | 97,276 | $5.04 | $490K | |
| Thomas Jeffrey Hargroves - Director | Open-market purchase | Warrant to Purchase Common Stock | 77,821 | $0.10 | $8K | |
| Thomas Jeffrey Hargroves - Director | Grant or award | Stock Option (right to Buy) | 15,000 | $0.00 | - | |
| Raul R. Silva - Officer | Grant or award | Stock Option (right to Buy) | 3,422 | $0.00 | - | |
| Raul R. Silva - Officer | Grant or award | Common Stock | 4,526 | $0.00 | - | |
| Raul R. Silva - Officer | Tax withholding / forfeiture | Common Stock | 1,828 | $0.00 | - | |
| Shane J. Schaffer - Officer | Grant or award | Common Stock | 6,862 | $0.00 | - | |
| Shane J. Schaffer - Officer | Tax withholding / forfeiture | Common Stock | 2,959 | $0.00 | - | |
| Jennifer L. Callahan - Officer | Grant or award | Common Stock | 15,329 | $0.00 | - | |
| Jennifer L. Callahan - Officer | Tax withholding / forfeiture | Common Stock | 6,427 | $0.00 | - | |
| Nilay Dahyabhai Patel - Officer | Grant or award | Common Stock | 5,475 | $0.00 | - | |
| Nilay Dahyabhai Patel - Officer | Tax withholding / forfeiture | Common Stock | 2,086 | $0.00 | - | |
| Matthew Brams - Officer | Grant or award | Common Stock | 4,526 | $0.00 | - | |
| Matthew Brams - Officer | Tax withholding / forfeiture | Common Stock | 1,025 | $0.00 | - | |
| Jennifer L. Callahan - Officer | Open-market purchase | Common Stock | 4,864 | $5.04 | $25K | |
| Jennifer L. Callahan - Officer | Open-market purchase | Warrant to Purchase Common Stock | 3,891 | $0.10 | $389 | |
| Peter J. Werth - Director | Open-market purchase | Common Stock | 19,455 | $5.04 | $98K | |
| Peter J. Werth - Director | Open-market purchase | Warrant to Purchase Common Stock | 15,564 | $0.10 | $2K | |
| Shane J. Schaffer - Officer | Open-market purchase | Common Stock | 6,809 | $5.04 | $34K | |
| Shane J. Schaffer - Officer | Open-market purchase | Warrant to Purchase Common Stock | 5,447 | $0.10 | $545 | |
| Matthew Brams - Officer | Open-market purchase | Common Stock | 1,946 | $5.04 | $10K | |
| Matthew Brams - Officer | Open-market purchase | Warrant to Purchase Common Stock | 1,556 | $0.10 | $156 | |
| Raul R. Silva - Officer | Grant or award | Stock Option (right to Buy) | 6,625 | $0.00 | - | |
| Raul R. Silva - Officer | Grant or award | Stock Option (right to Buy) | 7,334 | $0.00 | - | |
| Bryan Wade Downey - Officer | Grant or award | Stock Option (right to Buy) | 30,000 | $0.00 | - | |
| Nilay Dahyabhai Patel - Officer | Grant or award | Stock Option (right to Buy) | 30,000 | $0.00 | - | |
| Laurie Myers - Officer | Grant or award | Stock Option (right to Buy) | 31,000 | $0.00 | - | |
| Jennifer L. Callahan - Officer | Grant or award | Stock Option (right to Buy) | 64,500 | $0.00 | - | |
| Matthew Brams - Officer | Grant or award | Stock Option (right to Buy) | 52,500 | $0.00 | - | |
| Raul R. Silva - Officer | Grant or award | Stock Option (right to Buy) | 51,500 | $0.00 | - | |
| Shane J. Schaffer - Officer | Grant or award | Stock Option (right to Buy) | 199,500 | $0.00 | - | |
| Raul R. Silva - Officer | Grant or award | Stock Option (right to Buy) | 1,000 | $0.00 | - | |
| Raul R. Silva - Officer | Grant or award | Stock Option (right to Buy) | 1,000 | $0.00 | - |
Cingulate Inc. (CING) had 9 insider filings in the last 90 days, with the most recent on 2026-07-20. The full record for CING runs to 33 Form 4 filings, the earliest from 2024-10-01. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of CING were filed in the last 90 days. 10 purchases are on record for this company.
No insider sales of CING were filed in the last 90 days.
This page tracks CING Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add CING to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
